UniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LEXINGTON, Mass. and AMSTERDAM, Oct. 02, 2023 -- uniQure N.V. , a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the grant...